Results 21 to 30 of about 13,611 (195)

26. Glutamate Carboxypeptidase II (GCPII) Expression Changes in Denervated and Reinnervated Muscles [PDF]

open access: yesPlastic and Reconstructive Surgery, Global Open
Keith T. Kuo, BS   +15 more
doaj   +2 more sources

06. Imaging Muscle Denervation By Detecting Glutamate Carboxypeptidase Ii Expression With Positron Emission Tomography (PET) [PDF]

open access: yesPlastic and Reconstructive Surgery, Global Open
William Padovano, MD, MPHS   +8 more
doaj   +2 more sources

Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy

open access: yesBMC Cancer, 2022
Background Prostate-specific membrane antigen (PSMA) overexpression has been observed in the endothelial neovasculature of several solid malignancies.
Young Jae Ryu   +5 more
doaj   +1 more source

Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA) [PDF]

open access: yes, 2013
The aim of this study was to identify potential ligands of PSMA suitable for further development as novel PSMA-targeted peptides using phage display technology. The human PSMA protein was immobilized as a target followed by incubation with a 15-mer phage
A Ghosh   +48 more
core   +14 more sources

PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications

open access: yesDiagnostics, 2023
Prostate-specific membrane antigen (PSMA) is a 100 kD, 750 amino acid (AA) long type II transmembrane glycoprotein that has a short N-terminal intracellular domain with 19 AA, 24 AA transmembrane proteins and a large C-terminal extracellular domain with ...
Aadil Adnan, Sandip Basu
doaj   +1 more source

Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration. [PDF]

open access: yesPLoS ONE, 2015
Glutamate carboxypeptidase II (GCP-II) is a brain metallopeptidase that hydrolyzes the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) to NAA and glutamate.
Rana Rais   +9 more
doaj   +1 more source

The Nagging Question of the Function ofN-Acetylaspartylglutamate

open access: yesNeurobiology of Disease, 1997
N-Acetylaspartylglutamate (NAAG) is a neuropeptide found in millimolar concentrations in brain that is localized to subpopulations of glutamatergic, cholinergic, GABAergic, and noradrenergic neuronal systems. NAAG is released upon depolarization by a Ca2+
Joseph T. Coyle
doaj   +1 more source

Scientific Rationale for the Treatment of Cognitive Deficits from Long COVID

open access: yesNeurology International, 2023
Sustained cognitive deficits are a common and debilitating feature of “long COVID”, but currently there are no FDA-approved treatments. The cognitive functions of the dorsolateral prefrontal cortex (dlPFC) are the most consistently afflicted by long ...
Arman Fesharaki Zadeh   +2 more
doaj   +1 more source

Co-Catalytic Metallopeptidases as Pharmaceutical Targets [PDF]

open access: yes, 2003
Understanding the reaction mechanism of co-catalytic metallopeptidases provides a starting point for the design and synthesis of new molecules that can be screened as potential pharmaceuticals. Many of the enzymes that contain co-catalytic metallo-active
Bzymek, Krzysztof P.   +2 more
core   +2 more sources

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer

open access: yesCell Reports, 2019
Summary: N-acetyl-aspartyl-glutamate (NAAG) is a peptide-based neurotransmitter that has been extensively studied in many neurological diseases. In this study, we show a specific role of NAAG in cancer. We found that NAAG is more abundant in higher grade
Tu Nguyen   +26 more
doaj   +1 more source

Home - About - Disclaimer - Privacy